Form 4 for AKTX Akari Therapeutics Plc
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000950170-25-036486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-03-10 | 2025-03-06 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $1.12 | +406.2K | 3.03M | +15% | +$455.0K |
| DMI | 2025-03-10 | 2025-03-06 | AKTX | Patel Samir Rashmikant | Dir | A - Grant | $1.12 | +812.5K | 406.2K | New | +$910.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares representing Ordinary Shares | 2025-03-06 | A | A | 406,250 | $1.12 | 3,031,005 | I PranaBio Investments LLC | — | — | (F1) Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. (F2) On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |
| 2 | Derivative | Series B Warrants (Right to Buy) | 2025-03-06 | A | A | 406,250 | $1.12 | 406,250 | I PranaBio Investments LLC | $0.87 · 2025-03-06 to 2030-03-06 | 406,250 American Depositary Shares representing Ordinary Shares | (F2) On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |
| 3 | Derivative | Series A Warrants (Right to Buy) | 2025-03-06 | A | A | 406,250 | $1.12 | 406,250 | I PranaBio Investments LLC | $0.87 · 2025-03-06 to 2026-03-06 | 406,250 American Depositary Shares representing Ordinary Shares | (F2) On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. |